Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB (BREACH-TB)

NCT06568484 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06568484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06568484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB (BREACH-TB)
Lead sponsor
Johns Hopkins University
Phase
Phase 2/3
Overall status
Recruiting
Start date
May 8, 2026
Completion date
September 30, 2027
Enrollment
2,530 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, latent